BioCentury | Jun 8, 2015
Clinical News

Remitch nalfurafine regulatory update

...supply Remitch to Torii, which already markets the compound in Japan (see BioCentury, March 30). Toray Industries...
BioCentury | Mar 30, 2015
Clinical News

Remitch nalfurafine regulatory update

...rights to the product in North America. Mitsubishi Tanabe Pharma Corp . (Tokyo:4508), Osaka, Japan Toray Industries...
BioCentury | Mar 23, 2015
Financial News

Spectral Medical completes private placement

...C$5 million ($3.9 million) Shares: 9 million Price: C$0.55 Shares after offering: 188.8 million Investor: Toray Industries...
BioCentury | Jun 16, 2014
Financial News

Spectral Diagnostics proposes private placement

...C$18.2 million ($16.7 million) Shares: 45.1 million Price: C$0.29 Shares outstanding prior: 134.5 million Investors: Toray Industries...
BioCentury | Jan 27, 2014
Clinical News

Winfuran nalfurafine regulatory update

...rights in Europe (see BioCentury, Oct. 31, 2011). Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan Toray Industries...
BioCentury | Jan 6, 2014
Clinical News

Winfuran nalfurafine regulatory update

...rights in Europe (see BioCentury, Oct. 31, 2011). Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan Toray Industries...
BioCentury | Apr 8, 2013
Financial News

Spectral Diagnostics completes private placement

...C$5.6 million ($5.5 million) Shares: 18.7 million Price: C$0.30 Shares after offering: 119.9 million Investor: Toray Industries WIR...
BioCentury | Mar 25, 2013
Financial News

Spectral Diagnostics amends private placement

...C$5.6 million ($5.5 million) Shares: 18.7 million Price: C$0.30 Shares outstanding prior: 101.3 million Investor: Toray Industries...
BioCentury | Mar 18, 2013
Financial News

Spectral Diagnostics proposes private placement

...C$5 million ($4.9 million) Shares: 16.7 million Price: C$0.30 Shares outstanding prior: 101.3 million Investor: Toray Industries WIR...
BioCentury | Jan 14, 2013
Emerging Company Profile

Trevi: Pain to itch

...nalfurafine, an oral KOR agonist, both produced statistically significant reductions in itch, according to Good. Toray Industries...
...& Co. KGaA (Xetra:FRE), Bad Homburg, Germany Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Toray Industries...
Items per page:
1 - 10 of 30
BioCentury | Jun 8, 2015
Clinical News

Remitch nalfurafine regulatory update

...supply Remitch to Torii, which already markets the compound in Japan (see BioCentury, March 30). Toray Industries...
BioCentury | Mar 30, 2015
Clinical News

Remitch nalfurafine regulatory update

...rights to the product in North America. Mitsubishi Tanabe Pharma Corp . (Tokyo:4508), Osaka, Japan Toray Industries...
BioCentury | Mar 23, 2015
Financial News

Spectral Medical completes private placement

...C$5 million ($3.9 million) Shares: 9 million Price: C$0.55 Shares after offering: 188.8 million Investor: Toray Industries...
BioCentury | Jun 16, 2014
Financial News

Spectral Diagnostics proposes private placement

...C$18.2 million ($16.7 million) Shares: 45.1 million Price: C$0.29 Shares outstanding prior: 134.5 million Investors: Toray Industries...
BioCentury | Jan 27, 2014
Clinical News

Winfuran nalfurafine regulatory update

...rights in Europe (see BioCentury, Oct. 31, 2011). Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan Toray Industries...
BioCentury | Jan 6, 2014
Clinical News

Winfuran nalfurafine regulatory update

...rights in Europe (see BioCentury, Oct. 31, 2011). Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan Toray Industries...
BioCentury | Apr 8, 2013
Financial News

Spectral Diagnostics completes private placement

...C$5.6 million ($5.5 million) Shares: 18.7 million Price: C$0.30 Shares after offering: 119.9 million Investor: Toray Industries WIR...
BioCentury | Mar 25, 2013
Financial News

Spectral Diagnostics amends private placement

...C$5.6 million ($5.5 million) Shares: 18.7 million Price: C$0.30 Shares outstanding prior: 101.3 million Investor: Toray Industries...
BioCentury | Mar 18, 2013
Financial News

Spectral Diagnostics proposes private placement

...C$5 million ($4.9 million) Shares: 16.7 million Price: C$0.30 Shares outstanding prior: 101.3 million Investor: Toray Industries WIR...
BioCentury | Jan 14, 2013
Emerging Company Profile

Trevi: Pain to itch

...nalfurafine, an oral KOR agonist, both produced statistically significant reductions in itch, according to Good. Toray Industries...
...& Co. KGaA (Xetra:FRE), Bad Homburg, Germany Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Toray Industries...
Items per page:
1 - 10 of 30